IN SR0047

Urges the state department of health to study the feasibility, fiscal impact, and cost effectiveness of screening newborns for lysosomal storage disorders including Krabbe disease, Pompe disease, Niemann-Pick disease, Gaucher disease, Fabry disease, and Hurler syndrome

Notes these diseases have incidence rates of 1 in 5,000 to 1 in 10,000 people and that early detection enables more beneficial treatment compared to clinical detection after symptoms appear

Emphasizes that early identification would decrease the need for complex medical care and associated costs, but more information is needed regarding benefits, harms, and costs of newborn screening

References that nine other states have already mandated similar screening programs

Requires the state department of health to report its findings to the legislative council by October 30, 2016